Effect of Water Soluble Polymers on Dissolution Enhancement of Ibuprofen Solid Dispersion Prepared by Fusion Method

Authors

  • Riaz Uddin Lecturer, Department of Pharmacy, Stamford University Bangladesh
  • Nadia Saffoon Department of Pharmacy, The University of Asia Pacific, Dhanmondi, Dhaka
  • Naz Hasan Huda Department of Pharmacy, Stamford University Bangladesh
  • Yeakuty Marzan Jhanker Department of Pharmacy, The University of Asia Pacific, Dhanmondi, Dhaka

DOI:

https://doi.org/10.3329/sjps.v3i1.6801

Keywords:

Ibuprofen, polyethylene glycol, poloxomer, solid dispersion, fusion method, dissolution

Abstract

The purpose of this study was to prepare and characterize solid dispersions of the NSAID Ibuprofen with PEG 6000, Poloxomer 188 and Poloxomer 407 with the intention of improving its dissolution properties. The solid dispersions were prepared by the fusion method. Evaluation of the properties of the dispersions was performed using dissolution studies. The results obtained showed that the rate of dissolution of Ibuprofen was considerably improved when formulated in solid dispersions with PEG 6000 and poloxomer 188. Solid dispersions with poloxomer 407 showed drug retarding capability which may trigger more research in the intension of exploiting this feature to prepare sustained release dosage form.

Key words: Ibuprofen; polyethylene glycol; poloxomer; solid dispersion; fusion method; dissolution

DOI: 10.3329/sjps.v3i1.6801

S. J. Pharm. Sci. 3(1): 63-67

Downloads

Download data is not yet available.
Abstract
139
PDF
111

Downloads

How to Cite

Uddin, R., Saffoon, N., Huda, N. H., & Jhanker, Y. M. (2011). Effect of Water Soluble Polymers on Dissolution Enhancement of Ibuprofen Solid Dispersion Prepared by Fusion Method. Stamford Journal of Pharmaceutical Sciences, 3(1), 63–67. https://doi.org/10.3329/sjps.v3i1.6801

Issue

Vol. 3 No. 1 (2010)

Section

Research Articles

License

As a condition of publication, all authors must transfer copyright to the Department of Pharmacy. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur in the submission, and that the final version of the manuscript has been seen and approved by them.

Each author must agree to this statement

Authorship: This manuscript is the original work of the authors, each of whom has read and approved of the work. Each author satisfied the requirements contained in 'Author Guidelines' having participated sufficiently in the work to take public responsibility for the content. This participation includes:

  • Conception or design of the study, or analysis and interpretation of data, or both
  • Drafting the article or revising it for critically important intellectual content
  • Approval of the final 'to be published' version

All authors must take responsibility for the integrity of the work. Participating solely in the collection of data does not justify authorship.

Prior publication: This work is not currently under consideration by any other journal. Information about prior publication of any part of this work, or inclusion of patients detailed herein in any other work, has been provided in the cover letter.

Conflict of interest: Details of any financial or other relationship between any author and any other party that may lead to a conflict of interest with the subject or any materials mentioned in this article have been disclosed in the cover letter.